Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats

Drug Metabolism and Disposition

Volumn 28, Issue 5, 2000, Pages 514-521

  Paulson, Susan K ^a   Zhang, Ji Y ^a   Breau, Alan P ^a   Hribar, Jeremy D ^a   Liu, Norman W K ^a   Jessen, Susan M ^a   Lawal, Yvette M ^a   Cogburn, J Nita ^b   Gresk, Christopher J ^a   Markos, Charles S ^a   Maziasz, Timothy J ^a   Schoenhard, Grant L ^c   Burton, Earl G ^a  

^a PFIZER INC   (United States)

^b MONSANTO COMPANY   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG OXIDATION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BILE; BILE DUCTS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FECES; FEMALE; HALF-LIFE; INJECTIONS, INTRAVENOUS; MALE; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0034052783     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Davies P, Bailey PJ, Goldenberg MM and Ford-Hutchinson AW (1984) The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol 2:335-357.
2. DeWitt DL and Smith WL (1988) Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined by complimentary DNA sequence. Proc Natl Acad Sci USA 85:1412-1416.
3. Fu J-Y, Masferrer JL, Seibert K, Raz A and Needleman P (1990) The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 265:16737-16740
4. Isakson P, Zweifel B, Masferrer J, Koboldt C, Seibert K, Hubbard R, Geis S and Needleman P (1998) Specific COX-2 inhibitors: From bench to bedside, in Selective COX-2 Inhibitors: Pharmacology. Clinical Effects and Therapeutic Potential (Vane J and Botting J eds) pp. 127-133, Kluwer Academic Publishers and William Harvey Press, London, UK.
5. Kujubu DA, Fletcher BS, Varnum BC, Lim RW and Herschman HR (1991) TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266:12866-12872.
6. Masferrer JL, Zweifel BS, Seibert K and Needleman P (1990) Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 86:1375-1379.
7. Masferrer JL, Zweifel BS, Manning PT, Hauser DS, Leahy KM, Smith WG, Isakson PC and Seibert K (1994) Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91:3228-3232.
8. Merlie JP, Fagan D, Mudd J and Needleman P (1988) Isolation and characterization of sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J Biol Chem 263: 3550-3553.
9. Metzler CM, Elfring GK and McEween AJ (1974) A package of computer programs for pharmacokinetic modeling. Biometrics 30:562-563
10. Needleman P, Turk J, Jakschik BA, Morrison AR and Lefkowith JB (1986) Arachidonic acid metabolism. Annu Rev Biochem 55:69-102.
11. 14C] celecoxib in healthy male volunteers. Drug Metab Dispos 28:308-314.
12. Penning TD, Talley JJ, Bertenshaw SR, Carter JD, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM, Rogers RS, Rogier DJ, Yu SS, Anderson GD, Burton EG, Cogburn JN, Gregory SA, Koboldt CM, Perkins WE, Seibert K, Veenhuizen AW, Zhang YY and Isakson PC (1997) Synthesis and biological evaluation of the 1.5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] bezenesulfonamide (SC-58635, celecoxib). J Med Chem 40:1347-1365.
13. Robinson DR (1987) Lipid mediators of inflammation in rheumatic disease, in Clinics of North America (Zvaifler N ed) pp 385-405. WB Saunders Company, Philadelphia, PA.
14. Smith JB and Willis AL (1971) Aspirin selectivity inhibitors prostaglandins production in human platelets. Nat New Biol 231:235-237.
15. Spahn-Langguth H and Benet L (1992) Acyl glucuronides revisited: Is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab Rev 241:5-48.
16. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat tow Biol 231:232-235
17. Waxman DJ, Dannan GA and Guengerich FP (1985) Regulation of rat hepatic cytochrome P450: Age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry 24:4409-4417.
18. Xie W and Chipman JG (1991) Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88:2692-2696.